Eva Czirr, Dr rer Nat

Affiliations: 
Neurology Stanford University, Palo Alto, CA 
Area:
Neurodegeneration, Alzheimer's disease
Google:
"Eva Czirr"
Mean distance: 16.09 (cluster 31)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Le D, Liu A, Campbell MK, et al. (2020) Aged Plasma and Plasma‐Derived Factors Drive Detrimental Effects in the CNS of Young Mice The Faseb Journal. 34: 1-1
Gallager I, Kheifets V, Minami SS, et al. (2019) BENEFICIAL EFFECTS OF A PLASMA FRACTION ON NEUROGENESIS FOR AGE-RELATED COGNITIVE DISORDERS Innovation in Aging. 3: S90-S91
Czirr E, Castello NA, Mosher KI, et al. (2017) Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. The Journal of Experimental Medicine
Middeldorp J, Lehallier B, Villeda SA, et al. (2016) Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. Jama Neurology
Li WW, Guo TZ, Shi X, et al. (2014) Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 155: 2377-89
Kleinberger G, Yamanishi Y, Suárez-Calvet M, et al. (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine. 6: 243ra86
Kerchner GA, Czirr E, Bernstein JD, et al. (2014) P1-265: CEREBROSPINAL FLUID TAU, BUT NOT AMYLOID, TRACKS ATROPHY IN ALZHEIMER'S-VULNERABLE HIPPOCAMPAL SUBFIELDS Alzheimer's & Dementia. 10: P406-P406
Kerchner GA, Czirr E, Bernstein JD, et al. (2014) IC-P-166: CEREBROSPINAL FLUID TAU, BUT NOT AMYLOID, TRACKS ATROPHY IN ALZHEIMER-VULNERABLE HIPPOCAMPAL SUBFIELDS Alzheimer's & Dementia. 10: P93-P93
Lucin KM, O'Brien CE, Bieri G, et al. (2013) Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron. 79: 873-86
Czirr E, Wyss-Coray T. (2012) The immunology of neurodegeneration. The Journal of Clinical Investigation. 122: 1156-63
See more...